CN114651007A - 阳离子交换色谱期间的高盐洗涤以去除产品相关的杂质 - Google Patents

阳离子交换色谱期间的高盐洗涤以去除产品相关的杂质 Download PDF

Info

Publication number
CN114651007A
CN114651007A CN202080077533.3A CN202080077533A CN114651007A CN 114651007 A CN114651007 A CN 114651007A CN 202080077533 A CN202080077533 A CN 202080077533A CN 114651007 A CN114651007 A CN 114651007A
Authority
CN
China
Prior art keywords
sodium chloride
wash buffer
cation exchange
acetate
wash
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080077533.3A
Other languages
English (en)
Chinese (zh)
Inventor
M·R·安巴伊卡尔
L·迪亚兹
N·戈麦斯
B·J·蒂洛森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CN114651007A publication Critical patent/CN114651007A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202080077533.3A 2019-11-07 2020-11-04 阳离子交换色谱期间的高盐洗涤以去除产品相关的杂质 Pending CN114651007A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962931874P 2019-11-07 2019-11-07
US62/931,874 2019-11-07
PCT/US2020/058774 WO2021091933A1 (en) 2019-11-07 2020-11-04 High salt washes during cation exchange chromatography to remove product-realated impurities

Publications (1)

Publication Number Publication Date
CN114651007A true CN114651007A (zh) 2022-06-21

Family

ID=73598212

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080077533.3A Pending CN114651007A (zh) 2019-11-07 2020-11-04 阳离子交换色谱期间的高盐洗涤以去除产品相关的杂质

Country Status (14)

Country Link
US (1) US20220372071A1 (cg-RX-API-DMAC7.html)
EP (1) EP4055042A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022554283A (cg-RX-API-DMAC7.html)
KR (1) KR20220092958A (cg-RX-API-DMAC7.html)
CN (1) CN114651007A (cg-RX-API-DMAC7.html)
AR (1) AR120398A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020377919A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022008782A2 (cg-RX-API-DMAC7.html)
CA (1) CA3160208A1 (cg-RX-API-DMAC7.html)
CL (2) CL2022001169A1 (cg-RX-API-DMAC7.html)
IL (1) IL292602A (cg-RX-API-DMAC7.html)
MX (1) MX2022005594A (cg-RX-API-DMAC7.html)
TW (1) TWI878377B (cg-RX-API-DMAC7.html)
WO (1) WO2021091933A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023007028A (es) * 2020-12-18 2023-09-21 Kiniksa Pharmaceuticals Ltd Composiciones de proteínas y métodos para producir y usar las mismas.

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012125735A1 (en) * 2011-03-15 2012-09-20 Abott Laboratories An integrated approach to the isolation and purification of antibodies
CN104628846A (zh) * 2013-11-06 2015-05-20 上海中信国健药业股份有限公司 重组蛋白质的纯化方法
WO2015198320A1 (en) * 2014-06-24 2015-12-30 Insight Biopharmaceuticals Ltd. Methods of purifying antibodies
JP2016183113A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 Fc結合性タンパク質の精製方法
WO2017218977A2 (en) * 2016-06-17 2017-12-21 Genentech, Inc. Purification of multispecific antibodies
WO2019184549A1 (zh) * 2018-03-27 2019-10-03 广州爱思迈生物医药科技有限公司 双特异性抗体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555661B1 (en) * 1997-08-25 2003-04-29 Anthony R. Torres Simple, environmentally benign, method for purifying protein A
HUE024877T2 (en) * 2007-10-30 2016-02-29 Genentech Inc Antibody purification by cation exchange chromatography
US20120282654A1 (en) * 2009-04-29 2012-11-08 Schering Corporation Antibody purification
PL3177643T3 (pl) * 2014-08-04 2019-09-30 F.Hoffmann-La Roche Ag Dwuswoiste cząsteczki wiążące antygen aktywujące komórki T
EP3204415B1 (en) * 2014-10-09 2020-06-17 EngMab Sàrl Bispecific antibodies against cd3epsilon and ror1
JP2020525445A (ja) * 2017-06-21 2020-08-27 セファロン・インコーポレイテッドCephalon,Incorporated カチオン交換クロマトグラフィーの洗浄緩衝液

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012125735A1 (en) * 2011-03-15 2012-09-20 Abott Laboratories An integrated approach to the isolation and purification of antibodies
CN104628846A (zh) * 2013-11-06 2015-05-20 上海中信国健药业股份有限公司 重组蛋白质的纯化方法
WO2015198320A1 (en) * 2014-06-24 2015-12-30 Insight Biopharmaceuticals Ltd. Methods of purifying antibodies
JP2016183113A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 Fc結合性タンパク質の精製方法
WO2017218977A2 (en) * 2016-06-17 2017-12-21 Genentech, Inc. Purification of multispecific antibodies
WO2019184549A1 (zh) * 2018-03-27 2019-10-03 广州爱思迈生物医药科技有限公司 双特异性抗体及其应用

Also Published As

Publication number Publication date
JP2022554283A (ja) 2022-12-28
JP2026048656A (ja) 2026-03-17
CL2022001169A1 (es) 2023-01-27
TWI878377B (zh) 2025-04-01
IL292602A (en) 2022-07-01
TW202523676A (zh) 2025-06-16
MX2022005594A (es) 2022-06-09
WO2021091933A1 (en) 2021-05-14
EP4055042A1 (en) 2022-09-14
AU2020377919A1 (en) 2022-06-16
US20220372071A1 (en) 2022-11-24
TW202132323A (zh) 2021-09-01
CL2024001792A1 (es) 2024-11-08
KR20220092958A (ko) 2022-07-04
CA3160208A1 (en) 2021-05-14
BR112022008782A2 (pt) 2022-07-26
AR120398A1 (es) 2022-02-09

Similar Documents

Publication Publication Date Title
US20220119526A1 (en) A continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes
WO2022072291A1 (en) Cation exchange chromatography process
WO2021150996A1 (en) Methods for harvesting biomolecules
JP2026048656A (ja) 生成物関連不純物を除去するためのカチオン交換クロマトグラフィー中の高塩分洗浄
US20240174752A1 (en) Modulating product quality of asymmetric multispecific antibodies through the use of temperature
US20260070943A1 (en) A method for harvesting products from high cell density perfusion cell cultures
JP7760500B2 (ja) 生成物関連不純物を除去するためのカチオン交換クロマトグラフィー中の高塩分負荷コンディショニング
HK40070589A (en) High salt washes during cation exchange chromatography to remove product-realated impurities
HK40070045A (en) High salt load conditioning during cation exchange chromatography to remove product-realated impurities
EA047099B1 (ru) Кондиционирование с высокой солевой нагрузкой в ходе катионообменной хроматографии для удаления связанных с продуктом примесей
EA046702B1 (ru) Способы очистки биспецифических антител при помощи катионообменной хроматографии с использованием промывки с высоким содержанием соли
WO2025251034A1 (en) Purification method
JP2026505293A (ja) 細胞培養法
HK40051082A (en) A continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes
KR20230132470A (ko) 단백질 조성물 및 이를 생산하는 방법 및 사용하는방법

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40070589

Country of ref document: HK